Health

First Patient Successfully Treated With Base Editing Gene Therapy: Sickle Cell Survivor Thrives

Credit: Michael Goderre, Boston Childrens Hospital

Gene editing technology has been making significant strides in medical science, offering hope for individuals suffering from various genetic disorders. While CRISPR has already demonstrated success in treating sickle cell disease, a newer and more precise method known as base editing is now showing even greater potential. 

This revolutionary approach has recently been successfully demonstrated, offering a potential cure for patients like Braden Baptiste.

A Life Defined by Sickle Cell Disease

Braden Baptiste, a 20-year-old who has suffered from sickle cell disease since early childhood, has endured a lifetime of medical challenges. The condition caused him to experience frequent and severe pain crises, prolonged hospital stays, and even required hip replacements due to complications. 

At one point, his very survival was at risk when his abnormally shaped red blood cells struggled to deliver oxygen to his heart. However, thanks to a groundbreaking gene-editing procedure, Baptiste’s life has changed dramatically. 

“Now I’m going to the gym every day, doing cardio and weight lifting,” he shares, highlighting the stark contrast between his previous limitations and his newfound health.

Understanding Base Editing: A More Precise Approach

Traditional CRISPR technology works by creating breaks in DNA strands to facilitate genetic modifications. While effective, this method can sometimes introduce unintended alterations. In contrast, base editing is a much more precise tool that directly alters individual DNA bases—the fundamental building blocks of genetic code.

At Boston Children’s Hospital, where Baptiste received treatment, base editing is likened to a “spell check” for DNA. Using a CRISPR-based targeting system, the technique precisely modifies a single DNA base without making breaks in the genetic structure. 

The process involves four bases—adenine (A), cytosine (C), guanine (G), and thymine (T). Base editing can convert one base into another (such as C to T or A to G), thereby correcting mutations, silencing harmful genes, or activating beneficial ones.

The Science Behind Sickle Cell Disease and Base Editing

Sickle cell disease is caused by a genetic mutation in hemoglobin, an ancient adaptation designed to protect against malaria. However, in some cases, this mutation leads to the production of abnormally shaped red blood cells that obstruct blood flow and cause severe complications.

“Sickle cell disease has a broad spectrum of severity, and the severity and frequency of complications can wax and wane,” explains Matthew Heeney, MD, Baptiste’s long-time hematologist at Boston Children’s Hospital. 

“Unfortunately, Braden was quickly acquiring many of the chronic complications of sickle cell disease, including organ dysfunction affecting his kidneys, lungs, joints, and eyes,” Dr. Baptise adds. 

Baptiste’s Journey to a Cure

Baptiste became a candidate for an experimental base-editing trial known as BEACON. Before undergoing the treatment, doctors conducted a year of extensive testing to determine whether his body could endure the procedure in its weakened state.

In October 2023, doctors collected a sample of his blood stem cells, which were sent to a specialized facility for base editing. Meanwhile, Baptiste underwent chemotherapy to eliminate his diseased blood stem cells, creating space for the modified cells. By November, he was ready to receive his edited stem cells.

During his recovery, Baptiste occupied himself by watching all eight seasons of Suits on Netflix while waiting for the effects of the infusion to take hold. To the amazement of his doctors, his recovery was swift, and he was discharged just in time for Christmas Eve.

A New Lease on Life

Baptiste’s transformation has been nothing short of miraculous. “In my opinion, I’m perfect. I never felt fine before—before, ‘fine’ was moderate pain I could take deep breaths through. Now I’m more than fine. I’m operating in every way possible.”

With his newfound health, Baptiste is embracing an active lifestyle for the first time. “I used to always try to exercise, but every little movement would cause joint pain, and exhaustion would also cause pain,” he explains. “Now I’m going to the gym every day, doing cardio and weight lifting.”

The Future of Base Editing

Baptiste’s case is a testament to the potential of base editing as a safer and more precise alternative to traditional gene-editing technologies. While further research and trials are needed, this innovative technique could revolutionize the treatment of genetic disorders, offering a cure for conditions previously deemed untreatable.

The success of base editing in treating sickle cell disease opens doors for broader applications in medicine. From correcting genetic mutations to silencing disease-causing genes, base editing holds the promise of transforming lives and redefining what is possible in the field of genetic medicine.